Discover new therapies with cutting-edge research solutions

Propel your drug discovery with Synapmed’s expert preclinical services, which blend advanced AI and data analytics technology with Real World Data (RWD) and Real World Evidence (RWE) modeling to tackle scientific challenges. Our tailored approach helps you uncover novel therapy opportunities, providing the insights needed to drive innovation. By streamlining research processes and minimizing risks, we accelerate your path to discovering transformative therapies for further development.

Drive discovery with Generative AI + RWD/RWE expertise in preclinical research

These use case examples illustrate how our combined expertise in advanced intelligent automation and Real World Data (RWD) and Real World Evidence (RWE) and HEOR modeling can address complex scientific questions and accelerate your preclinical research. We help you uncover new therapy opportunities and navigate the discovery process with precision, setting the stage for successful drug development.

Proactively identify potential risks

Monitor adverse event trends pre-approval
Enhance safety profiling with real-world data-based insights
Predict and mitigate safety issues early in pre-clinical trial development
Support pre-clinical trial regulatory submissions with robust data

Discover new opportunities with data-driven insights

Use RWD to uncover and validate new molecular targets
Explore emerging indications for existing compounds
Apply RWE modeling to refine early-stage research hypotheses
Enhance compound screening with precise, evidence-based data

Leverage RWE modeling to expand the scope of drug development

Explore potential new uses and secondary indications for existing drugs
Identify novel therapeutic applications through real world data (RWD) analysis
Investigate new disease management pathways with real-world evidence (RWE) modeling
Validate early discovery compound and genomic-level leads with RWE insights

Enhance discovery efforts with RWD

Refine the selection process for preclinical compound screening
Predict molecular interactions and efficacy with RWD
Improve screening criteria using real-world evidence (RWE)
Increase the likelihood of identifying successful therapeutic agents

Improve research accuracy with real-world data insights

Enhance modeling relevance with RWD
Validate and adjust preclinical modeling based on real-world data analysis
Strengthen discovery outcomes with accurate modeling techniques and approaches
Ensure more reliable preclinical results through data integration

Bridge the gap between preclinical and clinical research

Apply RWE modeling to strengthen translational research processes
Validate preclinical findings with real-world evidence modeling
Improve the relevance of early discoveries to clinical applications
Increase confidence in translating research to therapeutic development

why synapmed?

We advance your drug discovery by leveraging a unique combination of the latest cutting-edge AI and data science technology, Real World Data (RWD) and Real World Evidence (RWE) and HEOR modeling, and specialized staff expertise.

Our preclinical services are designed to uncover new therapy opportunities, innovative molecules, and biomarker and cell/gene level – based medicines from initial research to detailed analysis. By integrating these capabilities , we help you identify novel targets, optimize research strategies, and streamline the discovery process, setting a foundation for breakthroughs in therapy development.

Services

RWD Analytics & RWE Modeling & HEOR

Leverage real-world patient data to enhance scientific and lab research. Our RWD analytics, RWE modeling and HEOR services provide crucial insights for therapy development, including modeling for toxicology, safety, and efficacy profiling.

RWD/Data Analytics Team Staffing

Integrate data science professional specialists with your lab, scientist and product developer

IMP Management

Effective IMP management involves comprehensive oversight of sourcing, distribution, temperature control, accountability, and disposal to ensure regulatory compliance and trial integrity.

Technology IMPLEMENTATIONS

Fuel your initiatives with our cutting-edge AI & data science technology services, driving innovation and operational excellence.

“Synapmed allows us to build expertise within our company while also outsourcing the administrative aspects. When you work with most vendors, it becomes an assembly line, and quality goes down. Or they take over completely, and we lose oversight. Synapmed is a part of my team, so we get to maintain and retain the quality.” 

“I build and fix departments and Synapmed has been part of that journey with me. We wanted to come up with a safety profile for one of our drugs. Because of the performance of competitor generics, it was getting a bad name. Synapmed mined the data, analyzed our product versus generics from a safety perspective, and wrote an article and abstract on the findings that was very productive.”

Real World Data (RWD) vs Real World Evidence (RWE)

Real World Data (RWD) and Real World Evidence (RWE) offer significant opportunities and challenges for pharmaceutical companies. RWD, derived from everyday patient product usage through channels such as electronic health records and social media, provides valuable insights into diverse populations, particularly post-marketing. While randomized clinical trial data remains the gold standard, regulators acknowledge RWD’s potential to enhance safety assessments. However, challenges like a lack of standardization in data collection and privacy concerns persist. The FDA addresses these issues through technologies like the My Studies App, which integrates data from various sources to improve patient care and reduce financial risks.

Dedicated to youR Project

No matter the size or scope of your projects, you have a committed partnership team with Synapmed. A team that listens, pays attention to details, and brings smart insights to the table. All so you can solve real problems throughout the product development and commercialization lifecycle.

Preclinical/R&D Services

Clinical Services

Regulatory Approval Services

Commercial Services